| Lewis Family Drug #41 | |
| 513 Broadway St, Centerville, South Dakota 57014 | |
| (605) 563-2243 |
| Name | Lewis Family Drug #41 |
|---|---|
| Organization Name | Lewis Family Drug Llc |
| Location | 513 Broadway St, Centerville, South Dakota 57014 |
| Type | Pharmacy |
| Phone | (605) 563-2243 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, based at RCSI, has partnered with global biopharmaceutical company, UCB, to unlock the power of healthcare data to inform improvements in clinical care of people with epilepsy.
The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.
Biodel Inc. announced today the award of two research grants by the Juvenile Diabetes Research Foundation to Stanford University and Oregon Health & Science University to evaluate the use of VIAject (ultra-rapid-acting injectable human insulin) in the treatment of diabetes.
Catalent Pharma Solutions announced today that Catalent, Inc. has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.
› Verified 2 days ago
| NPI Number | 1477081743 |
| Organization Name | LEWIS FAMILY DRUG, LLC |
| Doing Business As | LEWIS FAMILY DRUG #41 |
| Type | Pharmacy |
| Address | 513 Broadway St, Centerville, SD 57014 |
| Phone Number | 605-563-2243 |
News Archive
FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, based at RCSI, has partnered with global biopharmaceutical company, UCB, to unlock the power of healthcare data to inform improvements in clinical care of people with epilepsy.
The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.
Biodel Inc. announced today the award of two research grants by the Juvenile Diabetes Research Foundation to Stanford University and Oregon Health & Science University to evaluate the use of VIAject (ultra-rapid-acting injectable human insulin) in the treatment of diabetes.
Catalent Pharma Solutions announced today that Catalent, Inc. has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.
› Verified 2 days ago
| NPI Number | 1518062629 |
| Organization Name | PIONEER MEMORIAL HOSPITAL AND HEALTH SERVICES |
| Doing Business As | CENTERVILLE COMMUNITY PHARMACY |
| Type | Community/Retail Pharmacy |
| Address | 513 Broadway, Centerville, SD 57014 |
| Phone Number | 605-563-2243 |
News Archive
FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, based at RCSI, has partnered with global biopharmaceutical company, UCB, to unlock the power of healthcare data to inform improvements in clinical care of people with epilepsy.
The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.
Biodel Inc. announced today the award of two research grants by the Juvenile Diabetes Research Foundation to Stanford University and Oregon Health & Science University to evaluate the use of VIAject (ultra-rapid-acting injectable human insulin) in the treatment of diabetes.
Catalent Pharma Solutions announced today that Catalent, Inc. has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.
› Verified 2 days ago
News Archive
FutureNeuro, the SFI Research Centre for Chronic and Rare Neurological Diseases, based at RCSI, has partnered with global biopharmaceutical company, UCB, to unlock the power of healthcare data to inform improvements in clinical care of people with epilepsy.
The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.
Biodel Inc. announced today the award of two research grants by the Juvenile Diabetes Research Foundation to Stanford University and Oregon Health & Science University to evaluate the use of VIAject (ultra-rapid-acting injectable human insulin) in the treatment of diabetes.
Catalent Pharma Solutions announced today that Catalent, Inc. has publicly filed a registration statement with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of its common stock.
› Verified 2 days ago
Lewis Family Drug #41 Type: Pharmacy Location: 513 Broadway St, Centerville, South Dakota 57014 Phone: (605) 563-2243 |